Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sex Differences in Early/Unplanned Separation Among US Service Members With a History of Mild Traumatic Brain Injury.

The Journal of head trauma rehabilitation·2025

Same author

Efficacy of Polyunsaturated Fatty Acids as a Treatment for Post-traumatic Stress Disorder: A Systematic Review.

Military medicine·2024

Same author

Prevalence of PTSD in Active Duty Members with Mild Traumatic Brain Injury: Systematic Review and Meta-analysis.

Military medicine·2024

Same author

Baseline eHealth Behaviors of Service Members: A Retrospective, Cross-Sectional Analysis of Patient Portal Use Before the Pandemic.

Military medicine·2022

Same author

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.

Circulation·2019

Same author

Establishing the Genomic Knowledge Matrix for Nursing Science.

Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing·2018

Search research articles

Related Experiment Videos

Nutrigenomics in cardiovascular disease: implications for the future.

Mary B Engler¹

¹From the Department of Physiological Nursing, Laboratory of Cardiovascular Physiology, University of California, San Francisco, CA 94143-0610 , USA. mary.engler@nursing.ucsf.edu

Progress in Cardiovascular Nursing

|December 17, 2009

Summary

Nutrigenomics explores how diet and genetics interact to influence cardiovascular disease (CVD) risk. Understanding genetic variations can personalize nutrition for better CVD prevention and management.

Related Experiment Videos

Area of Science:

Cardiovascular Genetics
Nutrigenomics
Personalized Nutrition

Background:

Cardiovascular disease (CVD) is a leading global cause of death, influenced by both environmental and genetic factors.
Diet plays a crucial role in modifying CVD risk, and its interaction with genetic predispositions is a key research area.
Single nucleotide polymorphisms (SNPs) are significant contributors to human genetic variation and influence individual responses to diet.

Purpose of the Study:

To explore the interplay between diet and genetic variations in the context of cardiovascular disease risk.
To highlight the emerging role of nutrigenomics in understanding individual responses to dietary interventions for CVD prevention.
To emphasize the need for healthcare professionals to integrate genetic and genomic knowledge into cardiovascular care.

Main Methods:

Review of existing evidence on diet-gene interactions in cardiovascular health.
Analysis of whole genome and candidate gene association studies in cardiovascular genetics.
Examination of recent nutrigenomics research findings on genotype-specific dietary responses.

Main Results:

Genotype significantly influences individual responsiveness to dietary factors and nutrients that impact CVD risk.
Nutrigenomics research provides a basis for developing genotype-based personalized nutrition strategies.
Genetic factors are critical in understanding the complex multifactorial nature of CVD.

Conclusions:

Personalized nutrition, guided by nutrigenomics, holds promise for CVD prevention and health promotion.
Integrating genetic and genomic education for healthcare providers is essential for advancing cardiovascular care.
Further research in cardiovascular genetics and nutrigenomics is needed to optimize clinical practice and patient outcomes.